Substance Use Disorder Treatment and Recovery Loan Repayment Program Reauthorization Act of 2023
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Substance Use Disorder Treatment and Recovery Loan Repayment Program Reauthorization Act of 2023 is a legislative proposal introduced in the 118th Congress aimed at reauthorizing a federal loan repayment program. This program is designed to support professionals working in substance use disorder treatment and recovery by providing loan repayment assistance. The bill was referred to the Subcommittee on Health but did not advance further and is currently classified as failed or expired. No official summary or full text is available to provide detailed provisions or funding specifics.
This bill sought to continue federal support for loan repayment to professionals in substance use disorder treatment and recovery but did not progress beyond initial committee referral and has expired.
- The bill focuses on reauthorizing a loan repayment program for substance use disorder treatment and recovery professionals.
- It was introduced in the House of Representatives during the 118th Congress.
- The latest legislative action was referral to the Subcommittee on Health on December 17, 2024, with no further progress.
['Healthcare professionals specializing in substance use disorder treatment and recovery', 'Federal health agencies administering loan repayment programs', 'Organizations involved in substance use disorder treatment and recovery services']
['Lack of detailed information on funding levels and program administration limits assessment of fiscal impact.', 'No available text to evaluate oversight mechanisms or enforcement provisions.', 'Failure to advance past subcommittee referral may indicate challenges in legislative support or prioritization.']
The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health. It did not proceed further and is now classified as failed or expired. The absence of a summary and full text limits insight into legislative negotiations or stakeholder engagement.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If reauthorized, the loan repayment program could improve recruitment and retention of healthcare professionals in substance use disorder treatment, potentially enhancing service availability.', 'Failure to reauthorize may reduce financial incentives for professionals to enter or remain in this field, possibly impacting workforce capacity.']
The lack of publicly available bill text and official summary limits transparency and public understanding of the bill's specific provisions and fiscal implications. The bill's failure to advance beyond subcommittee referral suggests limited legislative momentum, which is important for stakeholders monitoring policy developments in health and substance use disorder treatment.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.